We provide you with 20 years of free, institutional-grade data for IQV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IQV. Explore the full financial landscape of IQV stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,230,973
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Cherofsky Keriann | Sale | -35 | $197.76 | $6,922 | 2025-07-30 |
Patel Bhavik | Sale | -84 | $197.76 | $16,612 | 2025-07-30 |
Sherbet Eric | Sale | -5,800 | $190.05 | $1,102,290 | 2025-07-25 |
Sherbet Eric | Derivatives Exercise | 11,870 | 2025-07-25 | ||
Cherofsky Keriann | Sale | -549 | $191.53 | $105,150 | 2025-07-25 |
LEONARD JOHN M | Grant, award...etc | 1,592 | 2025-04-25 | ||
DANHAKL JOHN G | Grant, award...etc | 1,592 | 2025-04-25 | ||
GOGGINS COLLEEN A | Grant, award...etc | 1,592 | 2025-04-25 | ||
Cherofsky Keriann | Sale | -16 | $206.97 | $3,312 | 2025-02-12 |
Bruehlman Ronald E | Sale | -907 | $206.97 | $187,722 | 2025-02-12 |
BOUSBIB ARI | Sale | -3,335 | $206.97 | $690,245 | 2025-02-12 |
BOUSBIB ARI | Derivatives Exercise | 40,000 | 2025-02-12 | ||
Sherbet Eric | Sale | -179 | $206.97 | $37,048 | 2025-02-12 |
STAUB W RICHARD | Sale | -141 | $206.97 | $29,183 | 2025-02-12 |
Patel Bhavik | Sale | -108 | $206.97 | $22,353 | 2025-02-12 |
DANHAKL JOHN G | Open Market Purchase | 1,275 | $200.58 | 2025-02-07 | |
Bruehlman Ronald E | Sale | -2,201 | $203.43 | $447,749 | 2025-01-30 |
Bruehlman Ronald E | Grant, award...etc | 6,286 | 2025-01-30 | ||
BOUSBIB ARI | Sale | -10,500 | $203.43 | $2,136,015 | 2025-01-30 |
BOUSBIB ARI | Grant, award...etc | 22,000 | 2025-01-30 | ||
STAUB W RICHARD | Sale | -479 | $203.43 | $97,443 | 2025-01-30 |
STAUB W RICHARD | Grant, award...etc | 1,571 | 2025-01-30 | ||
Cherofsky Keriann | Sale | -176 | $203.43 | $35,804 | 2025-01-30 |
Cherofsky Keriann | Grant, award...etc | 2,898 | 2025-01-30 | ||
Sherbet Eric | Sale | -605 | $203.43 | $123,075 | 2025-01-30 |
Sherbet Eric | Grant, award...etc | 2,356 | 2025-01-30 | ||
Patel Bhavik | Sale | -612 | $203.43 | $124,499 | 2025-01-30 |
Patel Bhavik | Grant, award...etc | 1,299 | 2025-01-30 | ||
Sherbet Eric | Sale | -1,300 | $246.33 | $320,229 | 2024-08-29 |
Cherofsky Keriann | Sale | -35 | $239.67 | $8,388 | 2024-07-30 |
Patel Bhavik | Sale | -83 | $239.67 | $19,893 | 2024-07-30 |
Patel Bhavik | Initial | 2024-05-17 | |||
DANHAKL JOHN G | Grant, award...etc | 1,047 | 2024-05-09 | ||
LEONARD JOHN M | Grant, award...etc | 1,047 | 2024-05-09 | ||
CONNAUGHTON JOHN | Grant, award...etc | 1,047 | 2024-05-09 | ||
GOGGINS COLLEEN A | Grant, award...etc | 1,047 | 2024-05-09 | ||
BOUSBIB ARI | Sale | -31,678 | $250.05 | $7,921,084 | 2024-03-04 |
BOUSBIB ARI | Derivatives Exercise | 42,847 | 2024-03-04 | ||
STAUB W RICHARD | Sale | -14,100 | $247.33 | $3,487,353 | 2024-03-04 |
Knightly Kevin C | Sale | -8,607 | $249.94 | $2,151,234 | 2024-03-01 |
Knightly Kevin C | Derivatives Exercise | 13,206 | 2024-03-01 | ||
Sherbet Eric | Sale | -1,000 | $241.5 | $241,500 | 2024-02-21 |
Knightly Kevin C | Sale | -13,468 | $240.72 | $3,242,017 | 2024-02-21 |
Knightly Kevin C | Derivatives Exercise | 12,149 | 2024-02-21 | ||
STAUB W RICHARD | Sale | -568 | $218.2 | $123,938 | 2024-02-13 |
Knightly Kevin C | Sale | -614 | $218.2 | $133,975 | 2024-02-13 |
Cherofsky Keriann | Sale | -76 | $218.2 | $16,583 | 2024-02-13 |
Sherbet Eric | Sale | -570 | $218.2 | $124,374 | 2024-02-13 |
BOUSBIB ARI | Sale | -7,244 | $218.2 | $1,580,641 | 2024-02-13 |
Bruehlman Ronald E | Sale | -1,940 | $218.2 | $423,308 | 2024-02-13 |
BOUSBIB ARI | Sale | -43,677 | $215.41 | $9,408,463 | 2024-02-08 |
BOUSBIB ARI | Grant, award...etc | 86,912 | 2024-02-08 | ||
Sherbet Eric | Sale | -2,372 | $215.41 | $510,953 | 2024-02-08 |
Sherbet Eric | Grant, award...etc | 7,725 | 2024-02-08 | ||
Knightly Kevin C | Sale | -2,688 | $215.41 | $579,022 | 2024-02-08 |
Knightly Kevin C | Grant, award...etc | 7,241 | 2024-02-08 | ||
Bruehlman Ronald E | Sale | -10,514 | $215.41 | $2,264,821 | 2024-02-08 |
Bruehlman Ronald E | Grant, award...etc | 24,141 | 2024-02-08 | ||
STAUB W RICHARD | Sale | -3,148 | $215.41 | $678,111 | 2024-02-08 |
STAUB W RICHARD | Grant, award...etc | 8,690 | 2024-02-08 | ||
Knightly Kevin C | Sale | -13,117 | $213.72 | $2,803,365 | 2023-12-05 |
Knightly Kevin C | Derivatives Exercise | 18,491 | 2023-12-05 | ||
STAUB W RICHARD | Initial | 2023-09-29 | |||
Panagos Constantinos | Derivatives Exercise | 26,186 | 2023-09-21 | ||
Panagos Constantinos | Sale | -27,317 | $208.69 | $5,700,785 | 2023-09-21 |
Bruehlman Ronald E | Sale | -2,588 | $216.29 | $559,759 | 2023-08-07 |
Cherofsky Keriann | Sale | -35 | $226.15 | $7,915 | 2023-08-01 |
Knightly Kevin C | Sale | -5,820 | $201.89 | $1,175,000 | 2023-06-07 |
Knightly Kevin C | Sale | -1 | $198.66 | $199 | 2023-05-31 |
GOGGINS COLLEEN A | Grant, award...etc | 1,063 | 2023-05-12 | ||
Wims Morris Leslie | Grant, award...etc | 1,063 | 2023-05-12 | ||
Burt Carol | Grant, award...etc | 1,063 | 2023-05-12 | ||
DANHAKL JOHN G | Grant, award...etc | 1,063 | 2023-05-12 | ||
Stamps Sheila A | Grant, award...etc | 1,063 | 2023-05-12 | ||
LEONARD JOHN M | Grant, award...etc | 1,063 | 2023-05-12 | ||
Fasano Jim | Grant, award...etc | 1,063 | 2023-05-12 | ||
Knightly Kevin C | Sale | -4,446 | $225.68 | $1,003,373 | 2023-02-17 |
Sherbet Eric | Sale | -1,000 | $230 | $230,000 | 2023-02-15 |
Cherofsky Keriann | Sale | -129 | $230.31 | $29,710 | 2023-02-13 |
BOUSBIB ARI | Sale | -7,593 | $230.31 | $1,748,744 | 2023-02-13 |
Sherbet Eric | Sale | -643 | $230.31 | $148,089 | 2023-02-13 |
Bruehlman Ronald E | Sale | -1,331 | $230.31 | $306,543 | 2023-02-13 |
Knightly Kevin C | Sale | -614 | $230.31 | $141,410 | 2023-02-13 |
Panagos Constantinos | Sale | -4,283 | $230.31 | $986,418 | 2023-02-13 |
Sherbet Eric | Sale | -3,267 | $235.84 | $770,489 | 2023-02-09 |
Sherbet Eric | Grant, award...etc | 8,745 | 2023-02-09 | ||
Knightly Kevin C | Sale | -2,090 | $235.84 | $492,906 | 2023-02-09 |
Knightly Kevin C | Grant, award...etc | 5,829 | 2023-02-09 | ||
BOUSBIB ARI | Sale | -44,014 | $235.84 | $10,380,262 | 2023-02-09 |
BOUSBIB ARI | Grant, award...etc | 87,459 | 2023-02-09 | ||
Panagos Constantinos | Sale | -1,341 | $235.84 | $316,261 | 2023-02-09 |
Panagos Constantinos | Grant, award...etc | 4,371 | 2023-02-09 | ||
Panagos Constantinos | Sale | -1,818 | $209.39 | $380,671 | 2022-11-03 |
Cherofsky Keriann | Initial | 2022-08-05 | |||
Bruehlman Ronald E | Sale | -2,588 | $233.21 | $603,547 | 2022-08-05 |
Rittenmeyer Ronald A | Grant, award...etc | 995 | 2022-05-13 | ||
Wims Morris Leslie | Grant, award...etc | 995 | 2022-05-13 | ||
DANHAKL JOHN G | Grant, award...etc | 995 | 2022-05-13 | ||
Burt Carol | Grant, award...etc | 995 | 2022-05-13 | ||
LEONARD JOHN M | Grant, award...etc | 995 | 2022-05-13 |
The information provided in this report about IQV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
IQVIA Holdings Inc(NYSE:IQV)

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contr...
Website: http://www.iqvia.com
Founded: 1982
Full Time Employees: 68,000
Sector: Healthcare
Industry: Diagnostics & Research